Chronic Hand Eczema and Other Regional Eczemas
The FDA’s approval of delgocitinib for chronic hand eczema is shining a light on this and other regional eczemas. Next Steps in Derm, in partnership with the ODAC Dermatology Conference, interviewed Peter A. Lio, MD, FAAD, clinical assistant professor of dermatology and pediatrics at the Northwestern University Feinberg School of Medicine. Watch as Dr. Lio shares the burden of chronic hand eczem …
The FDA’s approval of delgocitinib for chronic hand eczema is shining a light on this and other regional eczemas. Next Steps in Derm, in partnership with the ODAC Dermatology Conference, interviewed Peter A. Lio, MD, FAAD, clinical assistant professor of dermatology and pediatrics at the Northwestern University Feinberg School of Medicine. Watch as Dr. Lio shares the burden of chronic hand eczem … Continue reading "Chronic Hand Eczema and Other Regional Eczemas"
Following a high-energy kickoff, Day 2 of the 17th Annual Skin of Color Update (SOCU 2026) delivered a masterclass in complex inflammatory dermatoses, cutting-edge hair and scalp algorithms, and practical surgical management of keloids and nail emergencies.
Co-Chairs Andrew F. Alexis, MD, MPH, FAAD, and Eliot F. Battle, MD, welcomed attendees back to the main stage for another action-packed day o … 
Delgocitinib is a topical pan-Janus kinase (JAK) inhibitor that represents a novel non-steroidal treatment mechanism for chronic hand dermatitis. As a pan-JAK inhibitor, delgocitinib blocks all four members of the JAK family (JAK1, JAK2, JAK3, and tyrosine kinase 2 (TYK2)), thus simultaneously modulating the many cytokine pathways that drive chronic inflammatory skin disorders. Delgocitinib was in … 
Abrocitinib is an oral, once-daily selective Janus kinase 1 (JAK1) inhibitor approved for moderate-to-severe atopic dermatitis. It can provide rapid improvement in pruritus and skin disease and is a useful treatment option for many patients. As an oral medication, it may also be preferred by patients who want to avoid injections. When prescribing abrocitinib, it is important to discuss laboratory … 
When treating pediatric patients, knowing how to appropriately use topical steroids in this patient population is essential, according to Dr. Karan Lal, a dermatologist in Scottsdale, Ariz. Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Lal, who shares how to taper topical steroids and the role of non-steroidal agents. Hear the latest in the safety profile of topica …